Novozymes maintains investment plans despite pandemic
Covid-19 has thus far not impacted Novozymes' willingness to invest, the group's CFO says. The underlying growth and potential remain intact.
![Photo: Novo Nordisk / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12349496.ece/ALTERNATES/schema-16_9/doc7bxrnloqjab1c81tff8h.jpg)
Even though some of enzyme producer's investment plans were delayed due to the Covid-19 pandemic, Novozymes Chief Financial Officer Lars Green is not worried about the future, he tells Danish business media Finans in an interview.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.